The mechanism of Semaglutide starts with a signal

It borrows a familiar signal

GLP-1 is a hormone your gut releases after you eat. It helps the body handle blood sugar and regulate appetite. Semaglutide is an altered version that lasts longer.

You may see it called a “GLP-1 receptor agonist.” A receptor is a receiver on a cell; an agonist switches it on. The Wegovy (semaglutide injection and tablets) label describes that action. That's the useful part of the phrase to keep.

Blood sugar is part of the story

Semaglutide helps the body release insulin in response to blood sugar. Insulin helps control how much sugar stays in the blood. This helps explain why a medicine so often discussed for weight also has a diabetes role.

In SUSTAIN 1, adults with type 2 diabetes receiving semaglutide alone had a larger fall in HbA1c than those receiving placebo, a treatment without the active drug. HbA1c reflects average blood sugar over about three months. That result answers a diabetes question. It doesn't mean everyone needs lower blood sugar.

The rest of a person's medicine list matters. The label warns about low blood sugar when semaglutide is used with insulin or certain other diabetes medicines. An explanation of one drug can't replace a review of the whole list.

Appetite and the stomach both matter

Semaglutide also acts on appetite. The label describes receivers for GLP-1 in brain areas involved in appetite, and says semaglutide slows the movement of food out of the stomach. You may see that called “delayed gastric emptying.”

I'd keep those as parts of the explanation. Neither tells us exactly how every person will feel about food, or whether a particular product fits their health history.

Understanding it doesn't make side effects trivial

Nausea, vomiting, diarrhea and constipation were common digestive problems in weight-management trials. Most were mild or moderate and temporary. That describes the group; it can't tell someone how to judge a symptom today.

The label also warns about severe digestive reactions, gallbladder problems and pancreatitis, inflammation of the pancreas. I'd want a clinician to explain which symptoms need urgent attention and who can answer between appointments.

For why semaglutide lasts so long, there's a separate letter about its mechanism of action. For the appointment, a simpler question may do more work: “Which of these effects matters to the reason we're considering treatment?”